Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 5
2007 2
2008 4
2009 11
2010 11
2011 14
2012 15
2013 8
2014 14
2015 7
2016 3
2017 3
2018 7
2019 17
2020 19
2021 12
2022 16
2023 14
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

161 results

Results by year

Filters applied: . Clear all
Page 1
Inflammation and Prostate Cancer.
Tewari AK, Stockert JA, Yadav SS, Yadav KK, Khan I. Tewari AK, et al. Adv Exp Med Biol. 2018;1095:41-65. doi: 10.1007/978-3-319-95693-0_3. Adv Exp Med Biol. 2018. PMID: 30229548 Review.
AUTHOR REPLY.
Shukla D, Simma-Chiang V, Kyprianou N, Tewari AK, Lundon DJ. Shukla D, et al. Among authors: tewari ak. Urology. 2021 Nov;157:70. doi: 10.1016/j.urology.2021.04.052. Urology. 2021. PMID: 34895605 No abstract available.
Intratumor heterogeneity in prostate cancer.
Yadav SS, Stockert JA, Hackert V, Yadav KK, Tewari AK. Yadav SS, et al. Among authors: tewari ak. Urol Oncol. 2018 Aug;36(8):349-360. doi: 10.1016/j.urolonc.2018.05.008. Epub 2018 Jun 7. Urol Oncol. 2018. PMID: 29887240 Review.
Novel signatures of prostate cancer progression and therapeutic resistance.
Wang J, Ben-David R, Mehrazin R, Yang W, Tewari AK, Kyprianou N. Wang J, et al. Among authors: tewari ak. Expert Opin Ther Targets. 2023 Jul-Dec;27(12):1195-1206. doi: 10.1080/14728222.2023.2293757. Epub 2023 Dec 30. Expert Opin Ther Targets. 2023. PMID: 38108262 Review.
Molecular tracing of prostate cancer lethality.
Wang YA, Sfakianos J, Tewari AK, Cordon-Cardo C, Kyprianou N. Wang YA, et al. Among authors: tewari ak. Oncogene. 2020 Dec;39(50):7225-7238. doi: 10.1038/s41388-020-01496-5. Epub 2020 Oct 12. Oncogene. 2020. PMID: 33046797 Free PMC article. Review.
Anatomic robotic prostatectomy: current best practice.
Martini A, Tewari AK. Martini A, et al. Ther Adv Urol. 2019 Jan 8;11:1756287218813789. doi: 10.1177/1756287218813789. eCollection 2019 Jan-Dec. Ther Adv Urol. 2019. PMID: 30671135 Free PMC article. Review.
Pseudouridine as a novel biomarker in prostate cancer.
Stockert JA, Weil R, Yadav KK, Kyprianou N, Tewari AK. Stockert JA, et al. Among authors: tewari ak. Urol Oncol. 2021 Jan;39(1):63-71. doi: 10.1016/j.urolonc.2020.06.026. Epub 2020 Jul 22. Urol Oncol. 2021. PMID: 32712138 Free PMC article. Review.
Diagnostic Performance and Safety of Positron Emission Tomography with 18F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE).
Surasi DS, Eiber M, Maurer T, Preston MA, Helfand BT, Josephson D, Tewari AK, Somford DM, Rais-Bahrami S, Koontz BF, Bostrom PJ, Chau A, Davis P, Schuster DM, Chapin BF; LIGHTHOUSE Study Group. Surasi DS, et al. Among authors: tewari ak. Eur Urol. 2023 Oct;84(4):361-370. doi: 10.1016/j.eururo.2023.06.018. Epub 2023 Jul 5. Eur Urol. 2023. PMID: 37414702 Free article.
161 results